CLINICAL_TRIALS
research
· 2025-12-04
Clinical Trial Update: Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer [EARLY_Phase 1]
Summary
This entry notes an early-phase clinical trial investigating intermittent androgen deprivation therapy for Stage IV castration-sensitive prostate cancer, sponso…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Prostate Cancer, Stage IV Prostate Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING